Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Most frequent location of the sentinel lymph nodes.

Lo C, Lee PC, Yen RF, Huang CS.

Asian J Surg. 2014 Jul;37(3):125-9. doi: 10.1016/j.asjsur.2014.01.006. Epub 2014 Mar 15.

2.

A prospective comparative study to assess the contribution of radioisotope tracer method to dye-only method in the detection of sentinel lymph node in breast cancer.

Eser M, Kement M, Kaptanoglu L, Gecer M, Abamor E, Tutal F, Balin S, Kurt N, Uzun H.

BMC Surg. 2013 Apr 25;13:13. doi: 10.1186/1471-2482-13-13.

3.

Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.

van der Ploeg IM, Tanis PJ, Valdés Olmos RA, Kroon BB, Rutgers EJ, Nieweg OE.

Ann Surg Oncol. 2008 Nov;15(11):3239-43. doi: 10.1245/s10434-008-0120-y. Epub 2008 Sep 5.

PMID:
18773244
5.

Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.

Olson JA Jr, Fey J, Winawer J, Borgen PI, Cody HS 3rd, Van Zee KJ, Petrek J, Heerdt AS.

J Am Coll Surg. 2000 Dec;191(6):593-9.

PMID:
11129806
6.

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P.

Lancet. 1997 Jun 28;349(9069):1864-7.

PMID:
9217757
7.

[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].

Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.

Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Hungarian.

PMID:
24292111
8.

Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation.

Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):671-8.

PMID:
11597808
9.

Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid.

Lamichhane N, Shen KW, Li CL, Han QX, Zhang YJ, Shao ZM, Shen ZZ.

Postgrad Med J. 2004 Sep;80(947):546-50.

10.

Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.

Parmar V, Hawaldar R, Nair NS, Shet T, Vanmali V, Desai S, Gupta S, Rangrajan V, Mittra I, Badwe RA.

Breast. 2013 Dec;22(6):1081-6. doi: 10.1016/j.breast.2013.06.006. Epub 2013 Aug 13.

PMID:
23948301
11.

Identification of sentinel lymph node location based on body surface landmarks in early breast cancer patients.

Ueda N, Tada K, Miyata S, Koizumi M, Kuroda Y, Iwase T.

Breast Cancer. 2009;16(3):219-22. doi: 10.1007/s12282-008-0086-4. Epub 2008 Dec 18.

PMID:
19093169
12.

Clinical application of sentinel lymph node biopsy based on axillary anatomy in breast cancer: A single institution experience.

Kang B, Jun H, Lee K, Lee K, Kim S.

Breast. 2014 Dec;23(6):812-5. doi: 10.1016/j.breast.2014.08.012. Epub 2014 Sep 16.

PMID:
25224139
13.

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.

Breast Cancer. 2000 Jan;7(1):87-94.

PMID:
11029778
14.

Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.

Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK.

Clin Nucl Med. 2005 Jan;30(1):11-5.

PMID:
15604959
15.

Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.

Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM.

Breast Cancer Res Treat. 2003 Jan;77(1):9-14.

PMID:
12602900
16.

Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.

Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS.

Ann Surg. 2004 Jun;239(6):841-5; discussion 845-8.

17.

The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.

Asoglu O, Ozmen V, Karanlik H, Kecer M, Muzlumznoglu M, Igci A, Parlak M.

Acta Chir Belg. 2005 May-Jun;105(3):291-6.

PMID:
16018523
18.

Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.

Maza S, Thomas A, Winzer KJ, Hüttner C, Blohmer JU, Hauschild M, Richter M, Krössin T, Geworski L, Zander A, Guski H, Munz DL.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):671-5. Epub 2004 Jan 27.

PMID:
14745517
19.

Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.

Bassi KK, Seenu V, Ballehaninna UK, Parshad R, Chumber S, Dhar A, Gupta SD, Kumar R, Srivastava A.

Indian J Cancer. 2006 Jul-Sep;43(3):103-9.

20.

[Sentinel lymph node biopsy in breast cancer].

Luschin G.

Wien Med Wochenschr. 2010 Nov;160(19-20):497-500. doi: 10.1007/s10354-010-0830-1. Epub 2010 Oct 12. German.

PMID:
20936365
Items per page

Supplemental Content

Write to the Help Desk